| Mr Joel D Gardner, DO | |
|
950 S Medical Drive, Brigham City, UT 84302-3090 | |
| (435) 734-9471 | |
| (770) 701-6674 |
| Full Name | Mr Joel D Gardner |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 19 Years |
| Location | 950 S Medical Drive, Brigham City, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942329883 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 8821754-1204 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Brigham City Community Hospital | Brigham city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brigham Anesthesia, Llc | 9335108299 | 4 |
News Archive
Of the seven coronaviruses known to infect people, four cause common respiratory infections that are sharply seasonal and appear to transmit similarly to influenza, according to a new study by University of Michigan School of Public Health researchers.
Native American tribes gave up millions of acres to the federal government in the 19th century in exchange for promises of funded health care, education and housing. But time and again, those funds have been cut.
GeoVax Labs, Inc. (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that the U.S. Food and Drug Administration (FDA) has granted its request for a pre-IND meeting to discuss the proposed Investigational New Drug (IND) application for GeoVax's therapeutic vaccine as a treatment for individuals already infected with HIV.
CTI BioPharma Corp. announced today that pacritinib has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of intermediate and high risk myelofibrosis, including but not limited to patients with disease related thrombocytopenia, patients experiencing treatment emergent thrombocytopenia on other JAK2 therapy or patients who are intolerant to or whose symptoms are sub-optimally managed on other JAK2 therapy.
The National Sleep Foundation released its first international poll today, the 2013 International Bedroom Poll, comparing sleep times, attitudes, habits and bedtime routines of those in the United States, Canada, Mexico, the United Kingdom, Germany and Japan between the ages of 25 and 55 years old.
› Verified 4 days ago
| Entity Name | Brigham Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710904800 PECOS PAC ID: 9335108299 Enrollment ID: O20041006000807 |
News Archive
Of the seven coronaviruses known to infect people, four cause common respiratory infections that are sharply seasonal and appear to transmit similarly to influenza, according to a new study by University of Michigan School of Public Health researchers.
Native American tribes gave up millions of acres to the federal government in the 19th century in exchange for promises of funded health care, education and housing. But time and again, those funds have been cut.
GeoVax Labs, Inc. (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that the U.S. Food and Drug Administration (FDA) has granted its request for a pre-IND meeting to discuss the proposed Investigational New Drug (IND) application for GeoVax's therapeutic vaccine as a treatment for individuals already infected with HIV.
CTI BioPharma Corp. announced today that pacritinib has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of intermediate and high risk myelofibrosis, including but not limited to patients with disease related thrombocytopenia, patients experiencing treatment emergent thrombocytopenia on other JAK2 therapy or patients who are intolerant to or whose symptoms are sub-optimally managed on other JAK2 therapy.
The National Sleep Foundation released its first international poll today, the 2013 International Bedroom Poll, comparing sleep times, attitudes, habits and bedtime routines of those in the United States, Canada, Mexico, the United Kingdom, Germany and Japan between the ages of 25 and 55 years old.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Joel D Gardner, DO Po Box 3810, Salt Lake City, UT 84110-3810 Ph: (800) 594-6399 | Mr Joel D Gardner, DO 950 S Medical Drive, Brigham City, UT 84302-3090 Ph: (435) 734-9471 |
News Archive
Of the seven coronaviruses known to infect people, four cause common respiratory infections that are sharply seasonal and appear to transmit similarly to influenza, according to a new study by University of Michigan School of Public Health researchers.
Native American tribes gave up millions of acres to the federal government in the 19th century in exchange for promises of funded health care, education and housing. But time and again, those funds have been cut.
GeoVax Labs, Inc. (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that the U.S. Food and Drug Administration (FDA) has granted its request for a pre-IND meeting to discuss the proposed Investigational New Drug (IND) application for GeoVax's therapeutic vaccine as a treatment for individuals already infected with HIV.
CTI BioPharma Corp. announced today that pacritinib has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of intermediate and high risk myelofibrosis, including but not limited to patients with disease related thrombocytopenia, patients experiencing treatment emergent thrombocytopenia on other JAK2 therapy or patients who are intolerant to or whose symptoms are sub-optimally managed on other JAK2 therapy.
The National Sleep Foundation released its first international poll today, the 2013 International Bedroom Poll, comparing sleep times, attitudes, habits and bedtime routines of those in the United States, Canada, Mexico, the United Kingdom, Germany and Japan between the ages of 25 and 55 years old.
› Verified 4 days ago
David G Hess, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 950 Medical Dr, Brigham City, UT 84302 Phone: 800-594-6399 Fax: 801-733-5618 |